Home/ Supplements/ Niacin/ Ele-Max

Ele-Max

product on market Capsule Integrative Therapeutics Safety: 96/100
96/100

This product looks safe

  • Niacin: 100mg is 2.9× the Tolerable Upper Intake Level (35mg)
  • 70% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains B vitamins and amino acids like glycine and L-tyrosine, which are researched for their roles in energy metabolism and neurotransmitter synthesis. Evidence for these ingredients is generally strong, though overall product-specific evidence coverage is limited. The profile maintains a high safety score.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 100mg is 2.9× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for Ele-Max
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
30
Servings
Botanical with Nutrients
Product Type
70%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

100 mg (500% DV)
Exceeds UL by 2.9× (UL: 35 mg) 196 studies (A:5, B:63)
10 mg (500% DV)
7.7× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
400 mcg (100% DV)
Within RDA (1.0× RDA) 226 studies (A:10, B:105)
Glycine
400 mg
300 mg
Market median: 500.0mg (223 products) 24 studies (A:0, B:1)
Market median: 260.0mg (249 products) 158 studies (A:4, B:61)
100 mg
Market median: 100.0mg (116 products) 18 studies (A:0, B:3)
Market median: 120.0mg (440 products) 191 studies (A:1, B:71)
Eleuthero (Eleutherococcus senticosus) root extract
50 mg
Forskohlii (Plectranthus barbatus) root extract
30 mg

Other Ingredients

Hydroxypropyl Methylcellulose Microcrystalline Cellulose Ascorbyl Palmitate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Recommendation: Take 2 capsules daily, or as recommended by your healthcare professional.

Warnings & Precautions

Warning: This product should not be consumed by children under the age of 12 years or by pregnant or nursing women.

Warning: This product should not be consumed by children under the age of 12 years or by pregnant or nursing women.

Some may experience gastrointestinal (GI) upset including abdominal cramping, nausea, or diarrhea while taking this product. As with any supplement, if discomfort persists discontinue use. Those suffering from GI disorders such as ulcers, irritable bowel syndrome, Crohn’s disease, ulcerative colitis, or celiac disease, should not use 5-HTP.

Those taking prescription anti-depressants should not use 5-HTP. Do not take this product if you have or are taking medications for epilepsy, scleroderma, or Parkinson’s disease.

This product may cause drowsiness and should not be used while driving or operating heavy equipment.

If you are taking any medication, or have high blood pressure, consult your healthcare professional before use.

Formulation Notes

Contains no sugar, salt, yeast, wheat, gluten, corn, soy, dairy products, artificial colors, flavors or preservatives.

Additional Information

LZ246002.B01 B010114B

Mood balance

Metadata

Product Details

UPC / SKU8 71791 00292 0
DSLD Entry Date2017-09-21
Product TypeBotanical with Nutrients
FormCapsule
DSLD ID78354
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.